L-Annamycin + Cytarabine in Relapsed/Refractory AML

Market
100%75%50%25%0%Apr 13 • YES 32.0%Apr 13Apr 13 • YES 21.1%Apr 13
Trade

Will the results be positive?

Paper Trading
DetailsModel PositionsModel SnapshotsOracle
Oracle Findings
No oracle findings have been stored for this trial yet.
Stats
Latest Run
No runs yet
Model
No runs yet
Runs
0 runs